These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 23832632

  • 21. Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy.
    Rondón C, Blanca-López N, Campo P, Mayorga C, Jurado-Escobar R, Torres MJ, Canto G, Blanca M.
    Allergy; 2018 Apr; 73(4):905-915. PubMed ID: 29168570
    [Abstract] [Full Text] [Related]

  • 22. Subcutaneous versus sublingual immunotherapy.
    Lin CH, Alandijani S, Lockey RF.
    Expert Rev Clin Immunol; 2016 Aug; 12(8):801-3. PubMed ID: 27253418
    [No Abstract] [Full Text] [Related]

  • 23. [Vaccination with allergens in children].
    Demoly P, Dhivert-Donnadieu H, Bousquet J.
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [Abstract] [Full Text] [Related]

  • 24. Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?
    Nelson HS.
    J Allergy Clin Immunol Pract; 2014 Dec; 2(2):144-9; quiz 150-1. PubMed ID: 24607040
    [Abstract] [Full Text] [Related]

  • 25. Subcutaneous Versus Sublingual Immunotherapy for Adults with Allergic Rhinitis: A Systematic Review with Meta-Analyses.
    Tie K, Miller C, Zanation AM, Ebert CS.
    Laryngoscope; 2022 Mar; 132(3):499-508. PubMed ID: 33929726
    [Abstract] [Full Text] [Related]

  • 26. Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients.
    Pfaar O, Sager A, Robinson DS.
    Pediatr Allergy Immunol; 2015 May; 26(3):280-286. PubMed ID: 25640879
    [Abstract] [Full Text] [Related]

  • 27. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M, Eifan AO, Keles S, Akkoc T, Nursoy MA, Bahceciler NN, Barlan IB.
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [Abstract] [Full Text] [Related]

  • 28. The local and systemic side-effects of venom and inhaled-allergen subcutaneous immunotherapy.
    Adamic K, Zidarn M, Bajrovic N, Erzen R, Kopac P, Music E.
    Wien Klin Wochenschr; 2009 Sep; 121(9-10):357-60. PubMed ID: 19562302
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and Safety of Subcutaneous and Sublingual Immunotherapy for Allergic Rhinoconjunctivitis and Asthma.
    Roxbury CR, Lin SY.
    Otolaryngol Clin North Am; 2017 Dec; 50(6):1111-1119. PubMed ID: 28964530
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.
    Đurić-Filipović I, Caminati M, Kostić G, Filipović Đ, Živković Z.
    World J Pediatr; 2016 Aug; 12(3):283-290. PubMed ID: 27351563
    [Abstract] [Full Text] [Related]

  • 33. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P, Justicia JL, Sánchez C, Cimarra M, Fernández-Távora L, Orovitg A, Moreno C, Guerra F, Alvà V.
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [Abstract] [Full Text] [Related]

  • 34. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN, Cobanoglu N.
    Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
    [Abstract] [Full Text] [Related]

  • 35. Timothy grass pollen therapeutic vaccine: optimal dose for subcutaneous immunotherapy.
    Sola J, da Silva Ferreira JA, Dionicio Elera J, Plácido JL, Pereira C, Fonseca J, Panizo C, Inácio LF, Cancelleire N, Zubeldia Ortuño JM, Landeta A, Madariaga B, Martínez A.
    Immunotherapy; 2016 Jun; 8(3):251-63. PubMed ID: 26760111
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Subcutaneous immunotherapy for allergic rhinitis: an evidence based review of the recent literature with recommendations.
    Purkey MT, Smith TL, Ferguson BJ, Luong A, Reisacher WR, Pillsbury HC, Toskala E.
    Int Forum Allergy Rhinol; 2013 Jul; 3(7):519-31. PubMed ID: 23315962
    [Abstract] [Full Text] [Related]

  • 38. Effectiveness and adverse reactions to subcutaneous immunotherapy in children with allergic rhinitis/asthma.
    Duman Senol H, Topyildiz E, Ekici B, Gulen F, Demir E.
    Int J Pediatr Otorhinolaryngol; 2022 Nov; 162():111292. PubMed ID: 36007303
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma.
    Brüggenjürgen B, Reinhold T, Brehler R, Laake E, Wiese G, Machate U, Willich SN.
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):316-24. PubMed ID: 18814456
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.